The latest HPV genotyping technology: More accurate, Faster and More Comfortable
More than 70% of people, regardless of men and women, will be infected with HPV virus at least once, and more than 90% of the infection may be 24 months by their own immune system cleared, less than 10% will develop into persistent infection.
In addition to women, men will also be infected with HPV virus, increased suffering from anal cancer, oropharyngeal cancer and other risks. Therefore, it is necessary to detect HPV. HPV DNA detection is one of the most accurate methods.
The human papillomavirus (HPV) genotyping test will also result in different detection accuracy due to differences in detection techniques and reagents. In order to provide the best service and make the guests have a better service experience, Neo-Health Group has now introduced the world's leading molecular detection technology. To ensure a more accurate detection of various types of sexually transmitted diseases and HPV infection.
Anyplex™ II HPV28 Detection simultaneously detects 19 high-risk HPVs and 9 low-risk HPVs using DPO™ technology and melting curve analysis method of TOCE™ technology. 40 of HPV genotype cause infection in the genital area; they are classified as low-risk (HPV6, HPV11, cause of genital warts) and high-risk cause of cervical cancer. HPV16 and HPV18, a high-risk HPV genotype, accounted for more than 70% of the cause that leads to cervical cancer. Anyplex™ II HPV28 Detection has been specifically designed to address this unmet medical need through the simultaneous detection, identification and quantification of 28 HPV distinct genotypes (19 high-risk HPVs and 9 low-risk HPVs) contributing to cervical cancer and/or sexually transmitted infection within 6 hrs. It provides effective result by including internal control which checks the whole process from nucleic acid extraction and PCR.
Special Features of Seegene HPV 28
✓ Unique DPOTM & TOCETM PCR technology in Hong Kong
✓ WHO LabNet HPV genotyping test ***All achieved 100%-accuracy rating
✓ test accuracy: more than 95%
✓ Multiplex Real-time PCR
✓ Quantitative analysis using Cyclic-CMTA
✓ CE-IVD marked
Analytes 19 High-risk HPV genotype
16, 18, 26, 31, 33, 35, 39, 45, 51, 52,
53, 56, 58, 59, 66, 68, 69, 73, 82
9 Low-risk HPV genotype
6,11, 40, 42, 43, 44, 54, 61, 70
- Cervical swab specimen
- Liquid based cytology specimen
(e.g., ThinPrep® and SurePath™)